JENSCARE-B (09877) appointed Pan Fei as the new Chief Executive Officer.

15/01/2025

GMT Eight

Announcement: JENSCARE-B (09877) announces that in order to further promote the internationalization strategy of the group, comprehensively deepen and accelerate the global commercialization process, Mr. Lu Shiwen (Mr. Lu) has informed the company that he will resign as Chief Executive Officer (CEO) and has nominated Mr. Pan Fei (Mr. Pan) to serve as CEO. The appointment of the CEO has been unanimously approved by the company's Nomination Committee and Board of Directors on January 15, 2025.

Cofoe Medical Technology (301087.SZ) has set up Hunan Dingxin Kexin Entrepreneurship Investment Fund, which focuses on investing in the medical health and related industries.

Hubei Kailong Chemical Group (002783.SZ) is planning to change its controlling shareholder to the Hubei Provincial Government's State-owned Assets Supervision and Administration Commission.

Contact: contact@gmteight.com

JENSCARE-B (09877) appointed Pan Fei as the new Chief Executive Officer.

RECOMMEND

Guotai Junan: Highway Industry High Dividend Cash Flow Stable Policy Optimization May Accelerate

China Securities Co., Ltd.: Continue to actively deploy, corrections are opportunities.

Technical analysis indicates that the stock price is on the verge of rebounding, how can REMEGEN (09995) achieve long-term valuation regression after profit warning?